Related Experiment Video

Updated: Jul 15, 2025

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.2K

The management of sudden sensorineural hearing loss during COVID-19 pandemic

Paweł Rozbicki1, Jacek Usowski1, Jacek Siewiera2

  • 1Department of Otolaryngology and Laryngological Oncology with Clinical Department of Cranio-Maxillofacial Surgery, Military Institute of Medicine - National Research Institute, Warsaw.

Otolaryngologia Polska = the Polish Otolaryngology
|September 29, 2023
PubMed

Insights

The COVID-19 pandemic delayed treatment for Sudden Sensorineural Hearing Loss (SSNHL) and altered patient symptoms. This study highlights significant changes in SSNHL care and presentation during the pandemic.

Area of Science:

  • Otolaryngology
  • Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic presented challenges to healthcare systems globally.
  • Epidemiological restrictions impacted healthcare access and patient-reported symptoms for Sudden Sensorineural Hearing Loss (SSNHL).

Purpose of the Study:

  • To compare the timing of treatment initiation for SSNHL.
  • To analyze differences in reported symptoms among SSNHL patients before and during the COVID-19 pandemic.

Main Methods:

  • A survey was conducted with 34 SSNHL patients treated between October 1, 2021, and December 31, 2021.
  • Data collected included symptom presentation, comorbidities, and time to pharmacotherapy and hyperbaric oxygen therapy.
  • Results were compared with historical data from January 2017 to December 2019.

Main Results:

  • Patients during the pandemic experienced significantly longer delays in receiving pharmacotherapy (12.08 days) and hyperbaric oxygen therapy (17.5 days) compared to pre-pandemic (5.41 and 8.29 days, respectively).
  • A notable difference in the number and type of symptoms reported by SSNHL patients was observed between the two periods.

Conclusions:

  • The COVID-19 pandemic significantly impacted the management and clinical presentation of SSNHL.
  • Delayed treatment and altered symptomatology suggest potential links between SARS-CoV-2 and SSNHL, possibly exacerbated by pandemic-related healthcare access issues.

Keywords:
COVID-19hyperbaric medicinesudden sensorineural hearing loss

More Related Videos

Semi-Automated Analysis of Peak Amplitude and Latency for Auditory Brainstem Response Waveforms Using R06:01

Semi-Automated Analysis of Peak Amplitude and Latency for Auditory Brainstem Response Waveforms Using R

Published on: December 9, 2022

2.5K
High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology03:42

High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology

Published on: May 18, 2022

2.3K

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
131
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
41
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
16
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12